Cargando…

Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India

BACKGROUND & OBJECTIVES: Healthcare workers (HCWs) are considered to be at a high risk of contracting COVID-19 infection. Besides, control of nosocomial infections transmitted from HCWs to the patients is also a cause of concern. This study was undertaken to investigate the seroprevalence of ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ritu, Dwivedi, Tanima, Gajendra, Smeeta, Sahoo, Biswajeet, Gupta, Sanjeev Kumar, Vikas, H., Singh, Angel Rajan, Mohan, Anant, Bhatnagar, Sushma, Singh, Sheetal, Wundavalli, Laxmitej, Guleria, Randeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184075/
https://www.ncbi.nlm.nih.gov/pubmed/33642348
http://dx.doi.org/10.4103/ijmr.IJMR_3911_20
_version_ 1783704515405414400
author Gupta, Ritu
Dwivedi, Tanima
Gajendra, Smeeta
Sahoo, Biswajeet
Gupta, Sanjeev Kumar
Vikas, H.
Singh, Angel Rajan
Mohan, Anant
Bhatnagar, Sushma
Singh, Sheetal
Wundavalli, Laxmitej
Guleria, Randeep
author_facet Gupta, Ritu
Dwivedi, Tanima
Gajendra, Smeeta
Sahoo, Biswajeet
Gupta, Sanjeev Kumar
Vikas, H.
Singh, Angel Rajan
Mohan, Anant
Bhatnagar, Sushma
Singh, Sheetal
Wundavalli, Laxmitej
Guleria, Randeep
author_sort Gupta, Ritu
collection PubMed
description BACKGROUND & OBJECTIVES: Healthcare workers (HCWs) are considered to be at a high risk of contracting COVID-19 infection. Besides, control of nosocomial infections transmitted from HCWs to the patients is also a cause of concern. This study was undertaken to investigate the seroprevalence of antibodies against the SARS-CoV-2 virus among the hospital staff of a tertiary care health facility in north India. METHODS: The HCWs were tested for SARS-CoV-2 serology (IgG+IgM) using chemiluminescence immunoassay between June 22 and July 24, 2020. Venous blood (2 ml) was collected and tested for SARS-CoV-2 IgG and IgM antibodies. RESULTS: Of the 3739 HCWs tested, 487 (13%) were positive for total SARS-CoV-2 antibodies. The highest seroprevalence was observed in administrative staff (19.6%) and least in physicians (5.4%). The staff who used public (20%) and hospital transportation (16.9%) showed higher seroprevalence compared to staff using personal transportation (12.4%). No difference was observed between HCWs posted in COVID versus non-COVID areas. All seropositive symptomatic HCWs in our study (53.6%) had mild symptoms, and the remaining 46.4 per cent were asymptomatic. The antibody positivity rate progressively increased from 7.0 per cent in the first week to 18.6 per cent in the fourth week during the study. INTERPRETATION & CONCLUSIONS: The presence of antibodies to SARS-CoV-2 in a significant number of asymptomatic HCWs, association with the use of public transport, relatively lower seroprevalence compared with the non-HCWs and rising trend during the period of the study highlight the need for serosurveillance, creating awareness for infection control practices including social distancing and study of infection dynamics in the community for effective control of an infectious pandemic.
format Online
Article
Text
id pubmed-8184075
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-81840752021-06-21 Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India Gupta, Ritu Dwivedi, Tanima Gajendra, Smeeta Sahoo, Biswajeet Gupta, Sanjeev Kumar Vikas, H. Singh, Angel Rajan Mohan, Anant Bhatnagar, Sushma Singh, Sheetal Wundavalli, Laxmitej Guleria, Randeep Indian J Med Res Policy BACKGROUND & OBJECTIVES: Healthcare workers (HCWs) are considered to be at a high risk of contracting COVID-19 infection. Besides, control of nosocomial infections transmitted from HCWs to the patients is also a cause of concern. This study was undertaken to investigate the seroprevalence of antibodies against the SARS-CoV-2 virus among the hospital staff of a tertiary care health facility in north India. METHODS: The HCWs were tested for SARS-CoV-2 serology (IgG+IgM) using chemiluminescence immunoassay between June 22 and July 24, 2020. Venous blood (2 ml) was collected and tested for SARS-CoV-2 IgG and IgM antibodies. RESULTS: Of the 3739 HCWs tested, 487 (13%) were positive for total SARS-CoV-2 antibodies. The highest seroprevalence was observed in administrative staff (19.6%) and least in physicians (5.4%). The staff who used public (20%) and hospital transportation (16.9%) showed higher seroprevalence compared to staff using personal transportation (12.4%). No difference was observed between HCWs posted in COVID versus non-COVID areas. All seropositive symptomatic HCWs in our study (53.6%) had mild symptoms, and the remaining 46.4 per cent were asymptomatic. The antibody positivity rate progressively increased from 7.0 per cent in the first week to 18.6 per cent in the fourth week during the study. INTERPRETATION & CONCLUSIONS: The presence of antibodies to SARS-CoV-2 in a significant number of asymptomatic HCWs, association with the use of public transport, relatively lower seroprevalence compared with the non-HCWs and rising trend during the period of the study highlight the need for serosurveillance, creating awareness for infection control practices including social distancing and study of infection dynamics in the community for effective control of an infectious pandemic. Wolters Kluwer - Medknow 2021 /pmc/articles/PMC8184075/ /pubmed/33642348 http://dx.doi.org/10.4103/ijmr.IJMR_3911_20 Text en Copyright: © 2021 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Policy
Gupta, Ritu
Dwivedi, Tanima
Gajendra, Smeeta
Sahoo, Biswajeet
Gupta, Sanjeev Kumar
Vikas, H.
Singh, Angel Rajan
Mohan, Anant
Bhatnagar, Sushma
Singh, Sheetal
Wundavalli, Laxmitej
Guleria, Randeep
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India
title Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India
title_full Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India
title_fullStr Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India
title_full_unstemmed Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India
title_short Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India
title_sort seroprevalence of antibodies to sars-cov-2 in healthcare workers & implications of infection control practice in india
topic Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184075/
https://www.ncbi.nlm.nih.gov/pubmed/33642348
http://dx.doi.org/10.4103/ijmr.IJMR_3911_20
work_keys_str_mv AT guptaritu seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT dwiveditanima seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT gajendrasmeeta seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT sahoobiswajeet seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT guptasanjeevkumar seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT vikash seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT singhangelrajan seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT mohananant seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT bhatnagarsushma seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT singhsheetal seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT wundavallilaxmitej seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia
AT guleriarandeep seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia